Literature DB >> 12748370

Mycophenolate mofetil in treatment of idiopathic stages III-IV membranous nephropathy.

Momir Polenakovic, Ladislava Grcevska, Sonja Dzikova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12748370     DOI： 10.1093/ndt/gfg113

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  4 in total

1.  Mycophenolate mofetil and roscovitine decrease cyclin expression and increase p27(kip1) expression in anti Thy1 mesangial proliferative nephritis.

Authors:  M Chiara; E Menegatti; D Di Simone; A Davit; D Bellis; D Sferch; G De Rosa; O Giachino; L M Sena; D Roccatello
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

Review 2.  An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseases.

Authors:  Alice S Appel; Gerald B Appel
Journal:  Nat Clin Pract Nephrol       Date:  2009-01-27

Review 3.  Controversies in the treatment of idiopathic membranous nephropathy.

Authors:  Meryl Waldman; Howard A Austin
Journal:  Nat Rev Nephrol       Date:  2009-07-07       Impact factor: 28.314

Review 4.  Treatment of idiopathic membranous nephropathy.

Authors:  Meryl Waldman; Howard A Austin
Journal:  J Am Soc Nephrol       Date:  2012-08-02       Impact factor: 10.121
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.